Shi, Yuankai
Song, Yongping
Qin, Yan
Zhang, Qingyuan
Han, Xiaohong
Hong, Xiaonan
Wang, Dong
Li, Wei
Zhang, Yang
Feng, Jifeng
Yang, Jianmin
Zhang, Huilai
Jin, Chuan
Yang, Yu
Hu, Jianda
Wang, Zhao
Jin, Zhengming
Su, Hang
Wang, Huaqing
Yang, Haiyan
Fu, Weijun
Zhang, Mingzhi
Zhang, Xiaohong
Chen, Yun
Ke, Xiaoyan
Liu, Li
Yu, Ding
Chen, Guo’an
Wang, Xiuli
Jin, Jie
Sun, Tao
Du, Xin
Cheng, Ying
Yi, Pingyong
Zhao, Xielan
Ma, Chaoming
Cheng, Jiancheng
Chai, Katherine
Luk, Alvin
Liu, Eugene
Zhang, Xin
Funding for this research was provided by:
Chinese National Major Project for New Drug Innovation (2015ZX09501008, 2017ZX09304015)
CAMS Innovation Fund for Medical Science (CAMS Innovation Fund for Medical Science)
Article History
Received: 11 February 2020
Accepted: 1 April 2020
First Online: 16 April 2020
Ethics approval and consent to participate
: The protocol was developed by the sponsor of the study, Shanghai Henlius Biotech, Inc. The study protocol was reviewed and approved by the relevant independent ethics committee at each participating study center. Written informed consent was obtained from all study participants prior to screening. Data were collected by the site investigators who vouch for the completeness and accuracy of the data and the fidelity of the trial to the protocol. The sponsor analyzed the data. The study was conducted in accordance with the Declaration of Helsinki, Guideline for Good Clinical Practice, and applicable national and local regulations for clinical trials.
: Not applicable.
: CMM, JCC, KC, AL, EL, and XZ are employees of Shanghai Henlius Biotech, Inc. All other authors declare no competing interests.